Our results were consistent with the study by Nakano et al., which showed that SGLT-2 inhibition directly suppressed tumor‐releasing CXCL10, suggesting a potential mechanism for the antitumor effects of SGLT-2 inhibitors in hepatocellular carcinoma [30]. Here, SLC5A2 is linked to hepatocellular carcinoma.